Medical device startup, Diality Inc., has reached an agreement and partnership with Paramit Corp. for the upcoming manufacture of Diality’s hemodialysis system. Meeting a variety of critical and unmet patient and provider needs, the Diality device is part of a wave of unprecedented change in the dialysis industry—including a personalization and decentralization of therapy delivery.
“After an exhaustive search, we are thrilled to partner with a California based medical-device manufacturer with deep experience in complex electromechanical and fluidic systems including hemodialysis machines,” says Jahnavi Lokre, COO of Diality. “As we accelerate the commercialization effort for our system, we believe it is important to have a key strategic partner with a global manufacturing footprint and scale-up capability as well.”
The multi-year agreement establishes Paramit as the sole supplier of the capital components of Diality’s hemodialysis system.
“Paramit is proud to partner with Diality and manufacture such an impactful healthcare device,” says Jeff Johnson, VP of sales and marketing for Paramit. “Our capabilities and experience are well aligned to Diality’s technology, and we look forward to making their product realization goals a success.”
Founded in 2015, Diality is a privately held medical device company currently in development of a versatile hemodialysis machine useable at home or in a variety of care settings, including nursing homes, hospitals, transitional care facilities, and dialysis centers.
Committed to helping build a future where all patients and partners can control kidney disease, Diality is focused on developing solutions that help care providers improve the care and lives of patients with kidney disease while giving physicians the flexibility to prescribe personalized dialysis treatments regardless of delivery setting.
